Market Tracker

07/29 6:05pm ET

Incyte Corp (NASDAQ:INCY)

48.84
Data as of Jul 29
 +1.70 / +3.61%
Today’s Change
22.68
Today|||52-Week Range
70.86
-3.54%
Year-to-Date

Today’s Trading

Previous close47.14
Today’s open47.15
Day’s range46.89 - 49.06
Volume838,826
Average volume (3 months)1,512,079
Market cap$7.9B
Dividend yield--
Data as of 3:59pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+11.33%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.45-0.98%
JAZZJazz Pharmaceuticals...+3.29+2.40%
PCYCPharmacyclics Inc+16.25+14.98%
SLXPSalix Pharmaceutical...+0.16+0.12%
Data as of 4:02pm ET, 07/29/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)$0.10
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts